Hennion & Walsh Asset Management, Inc. Acadia Pharmaceuticals Inc Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.15 Billion
- Q1 2025
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 131,061 shares of ACAD stock, worth $1.95 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
131,061
Previous 103,325
26.84%
Holding current value
$1.95 Million
Previous $1.9 Million
17.99%
% of portfolio
0.1%
Previous 0.09%
Shares
17 transactions
Others Institutions Holding ACAD
# of Institutions
322Shares Held
165MCall Options Held
855KPut Options Held
350K-
Baker Bros. Advisors LP New York, NY42.9MShares$637 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$207 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$179 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.71MShares$129 Million2.61% of portfolio
-
Morgan Stanley New York, NY7.3MShares$108 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.4B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...